NEU neuren pharmaceuticals limited

Ann: Quarterly report and cash flow statement for Q4 2020, page-16

  1. 420 Posts.
    lightbulb Created with Sketch. 472
    Trip, I know you didn't ask the model question of me, but here is my 10c worth....if Trof is successful, then I would assume it will be for both Retts and Fragile x. If Phase 2 is successful on the 3x indications for 2591, then phase 3 success would be assumed (based on history) to be > 65%. This would actually be more, but let's say 65%.
    So, Trof passes phase 3 and 2591 passes phase 2. My model, which is on the conservative side per my detailed discussions with experts in this field, is $51 per share.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.